[go: up one dir, main page]

AU2001239953A1 - Methods of modulating cell-adhesion mediated drug resistance - Google Patents

Methods of modulating cell-adhesion mediated drug resistance

Info

Publication number
AU2001239953A1
AU2001239953A1 AU2001239953A AU3995301A AU2001239953A1 AU 2001239953 A1 AU2001239953 A1 AU 2001239953A1 AU 2001239953 A AU2001239953 A AU 2001239953A AU 3995301 A AU3995301 A AU 3995301A AU 2001239953 A1 AU2001239953 A1 AU 2001239953A1
Authority
AU
Australia
Prior art keywords
methods
drug resistance
modulating cell
mediated drug
adhesion mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239953A
Inventor
William S. Dalton
Jason S. Damiano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Florida St Petersburg
Original Assignee
University of South Florida
University of South Florida St Petersburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Florida, University of South Florida St Petersburg filed Critical University of South Florida
Publication of AU2001239953A1 publication Critical patent/AU2001239953A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001239953A 2000-03-01 2001-03-01 Methods of modulating cell-adhesion mediated drug resistance Abandoned AU2001239953A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18619900P 2000-03-01 2000-03-01
US60186199 2000-03-01
PCT/US2001/006466 WO2001064207A2 (en) 2000-03-01 2001-03-01 Methods of modulating cell-adhesion mediated drug resistance

Publications (1)

Publication Number Publication Date
AU2001239953A1 true AU2001239953A1 (en) 2001-09-12

Family

ID=22684023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239953A Abandoned AU2001239953A1 (en) 2000-03-01 2001-03-01 Methods of modulating cell-adhesion mediated drug resistance

Country Status (3)

Country Link
US (1) US20030004140A1 (en)
AU (1) AU2001239953A1 (en)
WO (1) WO2001064207A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001238714A1 (en) 2000-03-01 2001-09-12 University Of South Florida Compounds and methods for modulating cell-adhesion mediated drug resistance
GB0213261D0 (en) * 2002-06-10 2002-07-17 Anticancer Therapeutic Inv Sa Method
US7148210B2 (en) * 2002-10-15 2006-12-12 Trustees Of Dartmouth College Method of treating bone metastasis
EP1454994A1 (en) * 2003-03-07 2004-09-08 Université de la Méditerranée Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of MRD in leukemia
EP2649995A3 (en) * 2008-02-29 2014-05-21 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of post-radiation tumor growth
EP2473172B1 (en) * 2009-09-01 2015-04-08 Duke University Bisphosphonate compositions and methods for treating heart failure
US20130330761A1 (en) * 2012-06-12 2013-12-12 Celcuity, LLC Whole cell assays and methods
WO2015089380A2 (en) 2013-12-12 2015-06-18 Celcuity Llc Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent
EP3879269A3 (en) 2017-03-20 2021-11-17 Celcuity Inc. Methods of measuring signaling pathway activity for selection of therapeutic agents

Also Published As

Publication number Publication date
US20030004140A1 (en) 2003-01-02
WO2001064207A2 (en) 2001-09-07
WO2001064207A3 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2001241423A1 (en) Needleless syringe
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2001241963A1 (en) Improved medical procedure
AU2001289309A1 (en) Improved safety syringe
AU2001251304A1 (en) Ultrasonically activated electrodes
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2001274548A1 (en) Syringe
AU2001280598A1 (en) Anti-occlusion catheter
AU2002210463A1 (en) Transdermal therapeutic system
AU2001291019A1 (en) Method of modulating neovascularization
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU2001232948A1 (en) Controlled release of drugs
AUPR110100A0 (en) Improved separation of macromolecules
AU2001239953A1 (en) Methods of modulating cell-adhesion mediated drug resistance
AU2001271841A1 (en) Methods for identifying combinations of drugs
AU2002230704A1 (en) Selective, controlled manipulation of polymers
AU2001232244A1 (en) Drug comprising combination
AU2001280588A1 (en) Methods of modulating angiogenesis
AU2000244349A1 (en) Biodegradable disposable syringe
WO2001098454A8 (en) Human dna sequences
AU2001258659A1 (en) Improved methods of transfection
AU2002213420A1 (en) Single-use syringe
AU2001290147A1 (en) Transfection using plasmid preparations
AU2001238714A1 (en) Compounds and methods for modulating cell-adhesion mediated drug resistance